Indeed, specificity of DAT-SPECT is rather low, and it cannot reliably distinguish PD from atypical parkinsonisms (progressive supranuclear palsy-PSP, multiple system atrophy-MSA and CBS) in which there is a loss of striatonigral dopamine neurons as in PD. This evidence concerns the gene SLC6A3 and Parkinson disease.